CDK4 and non-small cell lung carcinoma: Emodin caused a dose and duration dependent decline in the proliferation of NSCLC cells, a G2/M phase cell cycle arrest, decreased in the cyclin-D1, CDK-2, and CDK-4 and an increase in cyclin-B1 protein levels.